drugset / Trial / NCT00293462
GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer
RandomizedCrossoverDouble-blindSupportive care
Summary
GM-CSF may protect normal cells from the side effects, such as mucositis, of radiation therapy and may help damaged tissue heal faster after radiation therapy. This randomized clinical trial is studying how well GM-CSF works in preventing and treating mucositis in patients who are undergoing radiation therapy for head and neck cancer.
Timeline
- Start
- 2005-06-07
- Primary completion
- 2009-12-31
- Completion
- 2009-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | sargramostim | Protein / enzyme biologic | — | Oral |